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Abstract: The aim of this study was to recognize the identity and frequency of 
etiologic agents of the pertussis-like syndrome in children < 2 years of age. A 
cross-sectional hospital-based study conducted from August 2014 to August 2015. 
All children < 2 years of age (n=100) who were suspected as pertussis infected 
were enrolled in this study and tested for Bordetella pertussis, adenovirus (Adv), 
respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and influenza 
virus A (INF-A) by real-time PCR technique. RSV was the most detected pathogen 
(20%), followed by B. pertussis (18%), Adv (16%), INF-A (11%), and hMPV (10%). 
Co-infection was observed in 8 patients (11%) and the combinations of RSV/INF-A 
(n=3, 4%), and AdV/B. pertussis (n=3, 4%) were more frequent. RSV, B. pertussis, and 
hMPV were more frequent pathogens among infants < 4 months of age. However, 
Adv and INF-A were more frequent pathogens among children > 6 months of age. 
In this study, RSV was the most frequent identified pathogen (n=20, 20%), followed 
by B. pertussis (n=18, 18%) and AdV (n=16, 16%). Pertussis was more frequent in 
This study was supported by a grant (No. 94-03-88-29448) from Tehran University  
of Medical Sciences to Dr. Setareh Mamishi.
Mailing Address: Dr. Setareh Mamishi, Department of Pediatric Infectious 
Disease, Children’s Medical Center Hospital, School of Medicine, Tehran University 
of Medical Sciences, No. 62, Gharib St., Keshavarz Blvd., Tehran, Iran; Phone:  
+98 021 6642 8996; Fax: +98 021 6642 8996; e-mail: smamishi@sina.tums.ac.ir
62) Prague Medical Report / Vol. 119 (2018) No. 1, p. 61–69
Mahmoudi S.; Banar M.; Pourakbari B.; Alavi H. S.; Eshaghi H.; Aziz Ahari A.; Mamishi S.
spring (8%) and summer (6%). In addition, clinical symptoms of pertussis were 
the same as some viral pathogens, which can lead to misdiagnosis of infection. 
Therefore, diagnosis of pertussis should be established on the bases of both the 
clinical symptoms and the laboratory methods.
Introduction
Bordetella pertussis is a fastidious gram-negative coccobacillus bacterium that 
causes pertussis (whooping cough), an acute infection of the respiratory tract in 
humans (Castillo et al., 2015; Pavic-Espinoza et al., 2015). Pertussis is one of the 
top ten fatal infections in children (Haghighi et al., 2014). Although it is a vaccine-
preventable disease, a considerable number of pertussis cases are yet recorded 
(Nunes et al., 2016). According to the World Health Organization (WHO), 
approximately 50 million cases of pertussis occur each year, which results in 
300 000 deaths (World Health Organization, 2016). Infants < 2 months are more 
susceptible to pertussis complications since they did not receive the pertussis 
vaccines (Nunes et al., 2016). The infant mortality rate of pertussis in developing 
countries is about 4% (World Health Organization, 2016). The well-known 
symptoms of pertussis defined as repeated paroxysmal cough, inspiratory whoop, 
and post-cough vomiting (Shojaei et al., 2014). The atypical milder infection can 
develop in persons with the prepared immune system either by vaccination or 
previous infection (Nunes et al., 2016).
Co-infections with respiratory viruses such as respiratory syncytial virus 
(RSV), rhinovirus/enterovirus, adenovirus (Adv), influenza virus (INF), and human 
metapneumovirus (hMPV) frequently occur in infants with pertussis infection 
(Dube et al., 2016; Nicolai et al., 2016). The clinical manifestations of these 
viral infections are indistinguishable from pertussis (Pavic-Espinoza et al., 2015); 
therefore, diagnosis of pertussis infection cannot be done only by clinical symptoms 
and should be confirmed by laboratory tests (del Valle-Mendoza et al., 2015). 
Real-time PCR is a rapid and sensitive technique that can be employed for fast 
detection of B. pertussis in order to disrupt its transmission and initiate appropriate 
therapy (Nikbin et al., 2013).
In this study, we aimed to recognize the identity and frequency of etiologic 
agents of the pertussis-like syndrome in children < 2 years of age who admitted to 
Children’s Medical Center (CMC) Hospital.
Material and Methods
Study design and population
This was a cross-sectional hospital-based study designed to recognize the identity 
and frequency of etiologic agents of the pertussis-like syndrome in all children 
< 2 years of age who were suspected to pertussis and admitted to CMC Hospital 
between August 2014 and August 2015. CMC Hospital is a tertiary referral 
children’s hospital that is located in Tehran, the capital city of Iran.
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Detailed demographic and clinical data such as age, gender, pertussis vaccination 
status, previous antibiotic consumption, history of pertussis in the family, and 
clinical symptoms were obtained from questionnaires that were answered by 
patient’s parents and from medical records. Children who met some of the 
WHO clinical case criteria for pertussis – i.e. cases with a cough more than 
two weeks with at least one of the following symptoms: paroxysm of a cough 
(many, rapid coughs followed by a high-pitched “whoop” sound); or inspiratory 
whoop (a forceful inspiration of air through a narrow glottis, usually developing 
after a paroxysmal cough); or vomiting after a cough; or apnea (long cessation 
of breathing) (with or without cyanosis (blue/purplish skin coloration due to 
lack of oxygen)) were included into the study (Shojaei et al., 2014; World Health 
Organization, 2016).
Ethical statement
This study was permitted by the Ethical Committee of the Research Center for 
Pediatric Infectious Diseases in Tehran University of Medical Sciences. Written 
informed consent was obtained from parents of all children.
Sample collection
For each patient, one Dacron swab was obtained from the posterior part of the 
nasopharynx and inoculated onto the 1 ml of sterile normal saline (0.9% W/V NaCl 
solution). All specimens were transported at room temperature within 1–2 hours 
to the microbiology laboratory of the Research Center for Pediatric Infectious 
Diseases at CMC Hospital and stored at –70 °C.
TaqMan real-time PCR
A TaqMan real-time PCR assay was applied to detect the identity of pathogens. 
For each specimen, both RNA and DNA were extracted from the elution liquid of 
swabs, using the MagJET viral DNA and RNA purification kit (Thermo ScientificTM, 
USA) and RTP bacteria DNA mini kit (STRATEC Biomedical AG, Germany) 
according to the manufacturer’s protocols. In the case of RNA samples, a random-
primed reverse transcription reaction was performed using the RevertAid reverse 
transcriptase kit (Thermo scientificTM, USA) and cDNA was synthesized according 
to the manufacturer’s instructions. The real-time PCR was performed based on the 
protocols of Adv, RSV, INF-A, hMPV and B. pertussis real-time PCR kits (Liferriver 
biotech, USA). An ABI step one real-time PCR system (Applied Biosystems, Foster 
City, California, USA) was used for this purpose.
Results
Study population
During the study period, a total of 100 children < 2 years of age (mean age 
5.5 months) presenting some of the symptoms of pertussis such as a paroxysmal 
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Table 1 – General and clinical characteristics of the patients
Characteristics Frequency (%)
Gender Male
Female
56
44
Age 0–2 month
2–4 month
4–6 month
6–18 month
≥ 18 month
34
30
12
20
4
Pertussis vaccination Yes 66
Contact with pertussis patients Yes 68
History of antibiotic consumption Yes 80
Clinical symptoms Paroxysmal cough
Cyanosis
Vomits
Apnea
100
44
52
30
cough, or post-tussive vomiting, or cyanosis, or apnea were included in the study. 
Demographics and clinical characteristics of the patients are summarized in Table 1. 
Fifty-six percent of cases were male, and 44% were female. Thirty-four percent of 
the patients were in the age group of 0 to 2 months and did not receive any doses 
of pertussis vaccine. The other remaining 66% of patients received doses of DTwP 
vaccine according to their age groups. Eighty percent of the children had a history 
of antibiotic consumption. A paroxysmal cough was the main complaint of patients 
and was observed in all cases. The duration of coughing varied from 6 to 30 days 
(mean duration 8.4 ± 3.9 days). The frequency of apnea was lower than other 
symptoms (30%).
TaqMan real-time PCR
From the 100 nasopharyngeal swabs tested by real-time PCR, 75% were positive 
for the presence of bacterial or viral nucleic acids. Among the detected pathogens, 
RSV showed the highest frequency (20%), followed by B. pertussis (18%), AdV (16%), 
INF-A (11%), and hMPV (10%). A dual infection was observed in 8 patients (11%), 
with combinations of RSV/INF-A (n=3, 4%), and AdV/B. pertussis (n=3, 4%) being 
more frequent, followed by RSV/B. pertussis (n=1, 1%) and AdV/RSV (n=1, 1%). One 
patient (1%) had a triple infection (AdV/RSV/B. pertussis). No simultaneous infection 
with hMPV was detected. In 25% of cases, no etiologic agent identified. Most cases 
of pertussis were observed during spring (n=8, 8%), followed by summer (n=6, 6%), 
autumn (n=1, 1%), and winter (n=3, 3%).
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Discussion
Although a paroxysmal cough is regarded as the most important classical symptom 
of pertussis and is used for pertussis clinical case definition by WHO and center 
for disease control and prevention (van den Brink et al., 2014), results of this 
study demonstrated that it is not a specific symptom for pertussis and of the 
100 suspected cases of pertussis, only 18% were correctly predicted by this 
criterion. In addition, other symptoms were non-specific to pertussis and they 
were also observed in some children with viral respiratory infections. In agreement 
with this study, other reports have emphasized on the lack of specificity of these 
classical symptoms (Shojaei et al., 2014; van den Brink et al., 2014; Vittucci et al., 
2016).
If pertussis diagnosis is based only on the clinical manifestations, atypical and 
mild infections would be unrecognized (van den Brink et al., 2014) especially in 
vaccinated children that show mild or less severe infection (van den Brink et al., 
2014); or other respiratory infections can be confused with pertussis (Shojaei et al., 
2014). This can lead to the consecutive spreading of the pathogen in the population 
and increases the danger of hospital outbreaks (van den Brink et al., 2014; Vittucci 
et al., 2016). The identification of pertussis cases should not be based only on the 
clinical symptoms (Cherry et al., 2012; van den Brink et al., 2014), and laboratory 
techniques such as real-time-PCR should be used as complementary diagnostic 
methods.
In this study, B. pertussis was detected only in 18% of suspected cases. In the 
study conducted by Hajia et al. (2012) from Tehran, Iran, 12 out of 138 children 
< 6 months (9%) were positive for B. pertussis, which was lower compared to the 
current result. Castillo et al. (2015) from Peru reported an incidence of pertussis 
as high as 40% in patients younger than one year admitted to five hospitals in Lima, 
Peru, which was higher than the rate of this study. Discrepancies observed among 
the pertussis frequency could be due to the different studied age ranges, different 
utilized diagnostic methods that have diverse sensitivity and specificity, and different 
vaccination coverage in various areas.
As noted, 80% of patients had used antibiotics before sampling that can cause 
false-negative results. However, since in the current study identification of the 
causative agents of the pertussis-like syndrome was performed by real-time 
PCR method, application of antibiotics could not affect the results. The rapid 
detection of etiologic agents of the pertussis-like syndrome plays an important 
role in stopping irrational antibiotic usage and adopting the correct therapeutic 
approaches.
Whooping cough vaccination program in Iran consists of three doses of DTwP 
vaccine (diphtheria and tetanus toxoid in combination with whole-cell pertussis) 
at the second, 4th and 6th months of life. Booster doses are given at 18 months 
and at 4 to 6 years of age (Sedaghat et al., 2014). In the current study, 89% (n=16) 
of pertussis cases were observed in the age group 0 to 6-month that were not 
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fully immunized and received only the three initial doses of DTwP vaccine. Some 
studies demonstrated that based on the efficiency of vaccine used, the infection 
can develop soon after the vaccination (van den Brink et al., 2014). Due to the 
waning efficacy of pertussis vaccine, adults play a significant role in the transmission 
of disease to the young infants (Sedighi and Sadrosadat, 2015). Therefore, some 
strategies are suggested for protection of unimmunized young infants, including 
revaccination of juveniles and adults with DTaP vaccine (acellular pertussis vaccine) 
to prevent household spread of infection, immunization of pregnant women during 
the third trimester of gestation that leads to the transfer of maternal anti-pertussis 
antibodies to the fetus to grant protection of newborns from pertussis prior their 
vaccination (Sedighi and Sadrosadat, 2015; Vittucci et al., 2016). Since whole-cell 
pertussis vaccine is not suggested for adults; and there is no access to acellular 
vaccine in Iran, it is recommended to introduce this type of vaccine into the Iranian 
national vaccination schedule (Sedighi and Sadrosadat, 2015).
In this research, RSV was the most prominent respiratory pathogen and was 
identified in 20% of the cases. In the previous study conducted at CMC Hospital 
(Pourakbari et al., 2014), RSV was the most prevalent viral pathogen (17.2%) 
isolated from nasopharyngeal aspirates of children < 5 years. According to the 
results, it can be stated that RSV is the principal cause of acute respiratory infection 
in children (Parsania et al., 2016); and further studies are required to determine the 
prevalence and genotype distribution of RSV in Iran (Salimi et al., 2016).
In this study, Adv and INF-A were detected in 16% and 11% of the patients, 
respectively. In the previous study carried out in CMC Hospital (Pourakbari et al., 
2014), Adv and INF-A showed the same frequencies (3.4%) and was lower than the 
rates of this study. In the study conducted by Naghipour et al. (2007) from Gilan, 
Iran, all the children < 5 years of age attending the out-patient clinics and those 
admitted to the hospital wards were tested; and Adv and INF-A was identified in 
14% and 4% of cases, respectively. In the study performed by Moattari et al. (2015) 
from Shiraz, Iran, nasopharyngeal swabs of 435 hospitalized children under 5 years 
of age were evaluated and 22% of patients were positive for Adv, which was higher 
than the rates of this study.
In this report, 10% of patients were positive for hMPV. Sanaei Dashti et al. 
(2016) from Shiraz, Iran, investigated 200 children under 12 years of age with 
upper respiratory tract complaints referred to Infectious Clinic of Mofid Children 
Hospital and reported a similar frequency for hMPV. However, in the studies 
conducted by Sultani et al. (2015) from Tehran, Iran (0%), and Vittucci et al. (2016) 
from Italy (3.4%) lower frequencies were reported. Furthermore, higher frequency 
for hMPV was reported by Moattari et al. (2015) from Shiraz, Iran (15.7%). The 
aforementioned differences in the frequency of Adv, INF-A, and hMPV in different 
studies could be due to the annual variations in the incidence of infections, the 
age of studied patients, different diagnostic methods used, the size of understudy 
population, and climate variations (Parsania et al., 2016).
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In the current study, co-infections with RSV/INF-A, AdV/B. pertussis, RSV/B. 
pertussis, AdV/RSV, and AdV/RSV/B. pertussis were detected in 8 patients (12%). 
Several studies revealed that in respiratory infections often more than one 
pathogen is detected. For instance, Korppi and Hiltunen (2007) reported the 
co-infection of RSV/B. pertussis in 7 out of 117 infants < 6 months of age who had 
lower respiratory tract infections. In the case of mixed infections, it is unclear 
which pathogen is the principal contributing agent and what is their association 
with disease severity. It is also unclear which pathogen is more important for 
the emergence of disease manifestations (van den Brink et al., 2014). Therefore, 
to avoid unrecognized cases, pertussis should be considered in all infants with 
respiratory tract infections and the diagnosis of viral pathogens does not mean that 
pertussis is dismissed.
In this research, the frequency of pertussis in spring and summer was higher 
than in the other seasons. This was similar to the reports of Ghorbani et al. (2016) 
from Iran that examined the nasopharyngeal swabs of all notified pertussis cases 
from different age groups between the years 2011 and 2013 and most of the 
confirmed cases of pertussis were identified during the spring and summer seasons. 
Gonfiantini et al. (2014) from Italy, evaluated the data on notified pertussis cases 
from 1888 to 2012 and observed similar season distribution to the current study. 
However, in the study performed by Goktas and Sirin (2016) from Turkey, most 
cases of pertussis (40%) were identified in winter. Consequently, being aware of 
the seasons with high rates of pertussis, it can be helpful to employ appropriate 
programs for active case finding and early treatment of patients in order to control 
quickly the spread of infection.
Conclusion
In this study, RSV was the most frequently identified pathogen (n=20, 20%), 
followed by pertussis (n=18, 18%) and AdV (n=16, 16%). Pertussis was more 
frequent at spring (8%) and summer (6%). In addition, clinical symptoms of 
pertussis were the same as that of some viral pathogens, and this can lead to 
misdiagnosis of infection. Therefore, diagnosis of pertussis should be based on both 
the clinical symptoms and the laboratory methods. Moreover, effective strategies 
for induction of immunity in unvaccinated young infants including revaccination of 
juveniles and adults with DTaP, and immunization of pregnant women during the 
third trimester of gestation; should be introduced into the public health control 
programs.
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